Clinical Problems Tied To Antiphospholipid Antibodies May Be Improved By Rituximab

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery...

Source: http://www.medicalnewstoday.com/releases/253088.php

Dead Leaves and the Dirty Ground This Chick Is Crazy Girls Just Want to Have Fun Have not Had Enough